Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for improving consciousness in diffuse axonal injury
IRCT20190810044500N26Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of modafinil in Diffuse axonal injury (DAI), sponsored by Shahid Sadoughi University of Medical Sciences. Started Aug 2024; status: completed.
02
Drugs
modafinil
03
Conditions
Diffuse axonal injury (DAI)
Beyond the preview
Go deeper on IRCT20190810044500N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N26.